Neville Young et al.
Journal of the National Cancer Institute, 98(15), 1060-1067 (2006-08-03)
The growth of solid tumors depends on establishing blood supply; thus, inhibiting tumor angiogenesis has been a long-term goal in cancer therapy. The SOX18 transcription factor is a key regulator of murine and human blood vessel formation. We established allograft